Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae
The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps...
Saved in:
Published in | Antimicrobial agents and chemotherapy Vol. 58; no. 6; pp. 3556 - 3559 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.06.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The contribution of drug efflux pumps in clinical isolates of
Neisseria gonorrhoeae
that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted. |
---|---|
AbstractList | The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted. The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted. The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted. |
Author | Golparian, Daniel Ohnishi, Makoto Unemo, Magnus Shafer, William M. |
Author_xml | – sequence: 1 givenname: Daniel surname: Golparian fullname: Golparian, Daniel organization: WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections (STIs), National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden – sequence: 2 givenname: William M. surname: Shafer fullname: Shafer, William M. organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA, Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center, Decatur, Georgia, USA – sequence: 3 givenname: Makoto surname: Ohnishi fullname: Ohnishi, Makoto organization: National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Magnus surname: Unemo fullname: Unemo, Magnus organization: WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections (STIs), National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28510068$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24733458$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56403$$DView record from Swedish Publication Index |
BookMark | eNqNkk1v1DAQhi1URLcLN84oFySQSLFjJ3EuSNFSYKUCFQKulteZ7Lpy7GA7QH8Ffxkvu91SBBIHaw7zzOv5eE_QkXUWEHpI8CkhBX_etotTjDHlOWF30IzghudV2VRHaIZxVeWMY3aMTkK4TFRK4HvouGA1pazkM_RjOYzOR2kVZK7P3k4m6s5P6-ys7830PbuYhjFk2mZxA1lrox608m6lpck-QNBhV3nh3Qg-Xm0lFkZbrVL-oJVfkzFbBmdkhLAF34EOAbyW2dpZ5_3GgYT76G4vTYAH-zhHn16dfVy8yc_fv14u2vNclpzFXJGGs6LBBHdp1I6pguMKA29UU_CaU1r3gBtWNrSDFeEr6Mu-K2WlGFaKVYTO0bOdbvgG47QSo9eD9FfCSS1e6s-tcH6d3iTKimGa8Bc7PLEDdAps9NLcqrqdsXoj1u6rYLhKjdZJ4MlewLsvE4QoBh0UGCMtuCkIUrKmoiWh9D9QyjirSRpzjp7uUBmGQly6ydu0NEGw2FpDJGuIX9YQhCX20e8jHHq_9kICHu8BGdL9ep9Oq8MNx0uSDMRvVpeMEIKH_oD849_iD1zpKKN220Vp8_ein1Jp464 |
CODEN | AACHAX |
CitedBy_id | crossref_primary_10_1093_nar_gkab213 crossref_primary_10_1136_sextrans_2019_054220 crossref_primary_10_1007_s00203_023_03663_0 crossref_primary_10_3389_fmicb_2015_01377 crossref_primary_10_1080_14728222_2017_1265105 crossref_primary_10_1080_1040841X_2019_1607248 crossref_primary_10_3389_fcimb_2022_924764 crossref_primary_10_1002_med_21591 crossref_primary_10_1038_s41467_020_17980_1 crossref_primary_10_1093_infdis_jiv517 crossref_primary_10_1007_s40203_023_00185_x crossref_primary_10_3389_fmicb_2021_776909 crossref_primary_10_3390_antibiotics10020103 crossref_primary_10_1128_msphere_00362_22 crossref_primary_10_2217_fmb_2017_0258 crossref_primary_10_1016_j_ijid_2016_11_409 crossref_primary_10_1128_mBio_02277_19 crossref_primary_10_1097_IM9_0000000000000024 crossref_primary_10_1042_EBC20160064 crossref_primary_10_1021_acsinfecdis_4c00091 crossref_primary_10_1099_mic_0_001257 crossref_primary_10_1128_AAC_00863_20 crossref_primary_10_1093_infdis_jiw420 crossref_primary_10_1128_mBio_01576_19 crossref_primary_10_1186_s12879_016_1469_3 crossref_primary_10_3390_genes12091312 crossref_primary_10_1136_sextrans_2014_051730 crossref_primary_10_1093_jac_dky162 crossref_primary_10_1093_jac_dkw182 crossref_primary_10_1038_s41579_018_0048_6 crossref_primary_10_1080_14737159_2022_2015329 crossref_primary_10_1007_s00253_023_12646_6 crossref_primary_10_3389_fmicb_2018_02971 crossref_primary_10_1071_SH19016 crossref_primary_10_1074_mcp_RA118_001125 crossref_primary_10_1016_j_micpath_2023_106182 crossref_primary_10_3390_antibiotics10050538 crossref_primary_10_1146_annurev_micro_090816_093530 crossref_primary_10_1093_cid_ciu526 crossref_primary_10_1016_j_clinmicnews_2015_12_006 crossref_primary_10_3389_fmicb_2020_00169 crossref_primary_10_1128_CMR_00010_14 crossref_primary_10_1128_CMR_00117_14 crossref_primary_10_1371_journal_ppat_1012783 crossref_primary_10_1371_journal_ppat_1008602 crossref_primary_10_1093_femspd_ftx041 crossref_primary_10_1016_j_trsl_2020_02_002 crossref_primary_10_1093_gbe_evx210 crossref_primary_10_1128_mBio_02281_18 crossref_primary_10_1128_AAC_01542_21 crossref_primary_10_1128_AAC_00821_18 crossref_primary_10_1099_acmi_0_000689_v3 crossref_primary_10_1097_OLQ_0000000000000971 crossref_primary_10_1128_AAC_01497_17 crossref_primary_10_1128_AAC_02798_15 crossref_primary_10_3390_vaccines10070983 crossref_primary_10_1093_femsre_fuac032 crossref_primary_10_1371_journal_ppat_1012578 crossref_primary_10_1021_acs_chemrev_1c00055 crossref_primary_10_1002_phar_1627 crossref_primary_10_1186_s40659_024_00543_9 crossref_primary_10_1016_S1473_3099_17_30310_9 crossref_primary_10_1007_s00430_019_00651_4 crossref_primary_10_1016_j_compbiolchem_2022_107682 crossref_primary_10_1016_j_meegid_2023_105449 crossref_primary_10_1093_jac_dky412 crossref_primary_10_3389_fmicb_2021_683901 crossref_primary_10_1093_jac_dkab024 crossref_primary_10_1016_j_drup_2016_06_007 crossref_primary_10_1038_s41598_017_16995_x crossref_primary_10_1128_AAC_00786_15 crossref_primary_10_1016_j_biomaterials_2015_02_063 |
Cites_doi | 10.1128/AAC.46.9.2811-2820.2002 10.1093/jac/dks162 10.1016/j.molmed.2005.06.006 10.1093/jac/dkt034 10.1128/AAC.05760-11 10.1177/0956462412472837 10.1099/13500872-141-3-611 10.1128/jb.177.14.4162-4165.1995 10.1073/pnas.95.4.1829 10.1128/AAC.02093-13 10.1111/j.1365-2958.2008.06424.x 10.1128/AAC.00325-11 10.1128/JB.185.3.1101-1106.2003 10.2217/fmb.12.117 10.1093/jac/dki333 10.1016/j.bcp.2005.12.008 10.2807/ese.16.06.19792-en 10.1021/bi101167x 10.1086/522964 10.1093/jac/dkt017 10.1093/jac/dkp098 10.1128/IAI.71.10.5576-5582.2003 10.1128/AAC.00304-09 10.1128/mBio.00187-11 10.1128/JB.01165-08 10.1099/00221287-144-3-621 10.2807/ese.15.47.19721-en 10.1128/AAC.43.10.2468 10.1128/JB.184.20.5619-5624.2002 10.1586/eri.09.63 10.1093/jac/dkl493 10.1056/NEJMp1112456 10.1136/sti.2010.042648 10.1001/jama.2012.176575 10.1007/s004380050196 10.1128/JB.188.7.2300-2308.2006 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright © 2014, American Society for Microbiology. All Rights Reserved. Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright © 2014, American Society for Microbiology. All Rights Reserved. – notice: Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7T7 8FD C1K FR3 P64 7X8 5PM ADTPV AOWAS D91 |
DOI | 10.1128/AAC.00038-14 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Örebro universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Engineering Research Database Technology Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Bacteriology Abstracts (Microbiology B) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Engineering Research Database MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1098-6596 |
EndPage | 3559 |
ExternalDocumentID | oai_DiVA_org_oru_56403 PMC4068427 00038-14 24733458 28510068 10_1128_AAC_00038_14 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R37 AI021150 – fundername: NIAID NIH HHS grantid: U19AI031496 – fundername: NIAID NIH HHS grantid: U19 AI031496 |
GroupedDBID | --- .55 .GJ 0R~ 23M 2WC 39C 3O- 4.4 53G 5GY 5RE 5VS 6J9 AAGFI AAYXX ACGFO ADBBV AENEX AGNAY AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HH5 HYE HZ~ H~9 J5H K-O KQ8 L7B LSO MVM NEJ O9- OK1 P2P RHI RNS RPM RSF TR2 UHB VH1 W2D W8F WH7 WHG WOQ X7M X7N XOL Y6R ZGI ZXP ~A~ IQODW CGR CUY CVF ECM EIF NPM RHF - 0R 55 AAPBV ABFLS ADACO BXI HZ ZA5 7QL 7T7 8FD C1K FR3 P64 7X8 5PM ADTPV AOWAS D91 |
ID | FETCH-LOGICAL-a584t-c198429010d596d4c28060e89c92878337fe094593deb18bef5fd5a6c40cc4613 |
ISSN | 0066-4804 1098-6596 |
IngestDate | Thu Aug 21 06:55:29 EDT 2025 Thu Aug 21 18:01:50 EDT 2025 Fri Jul 11 08:46:11 EDT 2025 Fri Jul 11 04:36:25 EDT 2025 Tue Dec 28 13:58:58 EST 2021 Thu Jan 02 22:17:14 EST 2025 Wed Apr 02 07:20:27 EDT 2025 Tue Jul 01 04:32:22 EDT 2025 Thu Apr 24 22:50:02 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Human Drug susceptibility test Neisseriaceae Antimicrobial agent Infection Sexually transmitted disease Gonococcal infection Neisseria gonorrhoeae Membrane pump Membrane transport Multiple resistance Bacteriosis Bacteria Micrococcales Clinical isolate |
Language | English |
License | CC BY 4.0 Copyright © 2014, American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a584t-c198429010d596d4c28060e89c92878337fe094593deb18bef5fd5a6c40cc4613 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://aac.asm.org/content/aac/58/6/3556.full.pdf |
PMID | 24733458 |
PQID | 1534847178 |
PQPubID | 23462 |
PageCount | 4 |
ParticipantIDs | swepub_primary_oai_DiVA_org_oru_56403 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4068427 proquest_miscellaneous_1549635133 proquest_miscellaneous_1534847178 asm2_journals_10_1128_AAC_00038_14 pubmed_primary_24733458 pascalfrancis_primary_28510068 crossref_primary_10_1128_AAC_00038_14 crossref_citationtrail_10_1128_AAC_00038_14 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-06-01 |
PublicationDateYYYYMMDD | 2014-06-01 |
PublicationDate_xml | – month: 06 year: 2014 text: 2014-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Antimicrobial agents and chemotherapy |
PublicationTitleAbbrev | Antimicrob Agents Chemother |
PublicationTitleAlternate | Antimicrob Agents Chemother |
PublicationYear | 2014 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 Centers for Disease Control and Prevention (CDC) (e_1_3_2_30_2) 2012; 61 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_14_2 e_1_3_2_35_2 Shafer WM (e_1_3_2_32_2) 2010 World Health Organization (e_1_3_2_2_2) 2012 18978065 - J Bacteriol. 2009 Jan;191(1):287-97 7711899 - Microbiology. 1995 Mar;141 ( Pt 3):611-22 16547016 - J Bacteriol. 2006 Apr;188(7):2300-8 21329645 - Euro Surveill. 2011;16(6). pii: 19792 20656721 - Sex Transm Infect. 2010 Nov;86(6):415-21 16427026 - Biochem Pharmacol. 2006 Mar 30;71(7):910-8 23231489 - Future Microbiol. 2012 Dec;7(12):1401-22 23390207 - J Antimicrob Chemother. 2013 Jun;68(6):1445-7 20704258 - Biochemistry. 2010 Sep 21;49(37):8062-70 19318360 - J Antimicrob Chemother. 2009 Jun;63(6):1142-51 12270819 - J Bacteriol. 2002 Oct;184(20):5619-24 22155830 - Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80 23416957 - J Antimicrob Chemother. 2013 Jun;68(6):1267-70 22566592 - J Antimicrob Chemother. 2012 Aug;67(8):1858-60 9465102 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1829-33 10508026 - Antimicrob Agents Chemother. 1999 Oct;43(10):2468-72 21576437 - Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45 14500476 - Infect Immun. 2003 Oct;71(10):5576-82 22316442 - N Engl J Med. 2012 Feb 9;366(6):485-7 16162665 - J Antimicrob Chemother. 2005 Nov;56(5):856-60 18761689 - Mol Microbiol. 2008 Oct;70(2):462-78 21933917 - MBio. 2011;2(5). pii: e00187-11. doi: 10.1128/mBio.00187-11 7608095 - J Bacteriol. 1995 Jul;177(14):4162-5 9534233 - Microbiology. 1998 Mar;144 ( Pt 3):621-7 24400344 - Int J STD AIDS. 2013 Feb;24(2):85-92 15996519 - Trends Mol Med. 2005 Aug;11(8):382-9 12533487 - J Bacteriol. 2003 Feb;185(3):1101-6 12183233 - Antimicrob Agents Chemother. 2002 Sep;46(9):2811-20 8709956 - Mol Gen Genet. 1996 Jul 19;251(5):509-17 18190261 - J Infect Dis. 2007 Dec 15;196(12):1804-12 19735224 - Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34 19528266 - Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51 22874837 - MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4 23299608 - JAMA. 2013 Jan 9;309(2):163-70 24189248 - Antimicrob Agents Chemother. 2014;58(1):624-5 17229832 - J Antimicrob Chemother. 2007 Jun;59(6):1223-9 21144442 - Euro Surveill. 2010 Nov 25;15(47). pii: 19721 |
References_xml | – ident: e_1_3_2_19_2 doi: 10.1128/AAC.46.9.2811-2820.2002 – ident: e_1_3_2_14_2 doi: 10.1093/jac/dks162 – ident: e_1_3_2_40_2 doi: 10.1016/j.molmed.2005.06.006 – ident: e_1_3_2_9_2 doi: 10.1093/jac/dkt034 – ident: e_1_3_2_8_2 doi: 10.1128/AAC.05760-11 – ident: e_1_3_2_31_2 doi: 10.1177/0956462412472837 – ident: e_1_3_2_33_2 doi: 10.1099/13500872-141-3-611 – ident: e_1_3_2_27_2 doi: 10.1128/jb.177.14.4162-4165.1995 – ident: e_1_3_2_34_2 doi: 10.1073/pnas.95.4.1829 – ident: e_1_3_2_26_2 doi: 10.1128/AAC.02093-13 – ident: e_1_3_2_37_2 doi: 10.1111/j.1365-2958.2008.06424.x – ident: e_1_3_2_13_2 doi: 10.1128/AAC.00325-11 – ident: e_1_3_2_24_2 doi: 10.1128/JB.185.3.1101-1106.2003 – ident: e_1_3_2_4_2 doi: 10.2217/fmb.12.117 – ident: e_1_3_2_23_2 doi: 10.1093/jac/dki333 – ident: e_1_3_2_39_2 doi: 10.1016/j.bcp.2005.12.008 – ident: e_1_3_2_11_2 doi: 10.2807/ese.16.06.19792-en – ident: e_1_3_2_15_2 doi: 10.1021/bi101167x – ident: e_1_3_2_36_2 doi: 10.1086/522964 – ident: e_1_3_2_12_2 doi: 10.1093/jac/dkt017 – ident: e_1_3_2_25_2 doi: 10.1093/jac/dkp098 – ident: e_1_3_2_35_2 doi: 10.1128/IAI.71.10.5576-5582.2003 – ident: e_1_3_2_16_2 doi: 10.1128/AAC.00304-09 – volume-title: Global incidence and prevalence of selected curable sexually transmitted infections—2008 year: 2012 ident: e_1_3_2_2_2 – ident: e_1_3_2_18_2 doi: 10.1128/mBio.00187-11 – ident: e_1_3_2_17_2 doi: 10.1128/JB.01165-08 – ident: e_1_3_2_29_2 doi: 10.1099/00221287-144-3-621 – ident: e_1_3_2_7_2 doi: 10.2807/ese.15.47.19721-en – ident: e_1_3_2_22_2 doi: 10.1128/AAC.43.10.2468 – ident: e_1_3_2_21_2 doi: 10.1128/JB.184.20.5619-5624.2002 – ident: e_1_3_2_3_2 doi: 10.1586/eri.09.63 – ident: e_1_3_2_38_2 doi: 10.1093/jac/dkl493 – ident: e_1_3_2_5_2 doi: 10.1056/NEJMp1112456 – ident: e_1_3_2_6_2 doi: 10.1136/sti.2010.042648 – ident: e_1_3_2_10_2 doi: 10.1001/jama.2012.176575 – start-page: 245 volume-title: Neisseria: molecular mechanisms of pathogenesis year: 2010 ident: e_1_3_2_32_2 – volume: 61 start-page: 590 year: 2012 ident: e_1_3_2_30_2 article-title: Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer recommended for treatment of gonococcal infections publication-title: MMWR Morb. Mortal. Wkly. Rep. – ident: e_1_3_2_28_2 doi: 10.1007/s004380050196 – ident: e_1_3_2_20_2 doi: 10.1128/JB.188.7.2300-2308.2006 – reference: 22566592 - J Antimicrob Chemother. 2012 Aug;67(8):1858-60 – reference: 23231489 - Future Microbiol. 2012 Dec;7(12):1401-22 – reference: 22155830 - Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80 – reference: 14500476 - Infect Immun. 2003 Oct;71(10):5576-82 – reference: 15996519 - Trends Mol Med. 2005 Aug;11(8):382-9 – reference: 17229832 - J Antimicrob Chemother. 2007 Jun;59(6):1223-9 – reference: 7711899 - Microbiology. 1995 Mar;141 ( Pt 3):611-22 – reference: 16162665 - J Antimicrob Chemother. 2005 Nov;56(5):856-60 – reference: 19318360 - J Antimicrob Chemother. 2009 Jun;63(6):1142-51 – reference: 23390207 - J Antimicrob Chemother. 2013 Jun;68(6):1445-7 – reference: 21144442 - Euro Surveill. 2010 Nov 25;15(47). pii: 19721 – reference: 21329645 - Euro Surveill. 2011;16(6). pii: 19792 – reference: 20704258 - Biochemistry. 2010 Sep 21;49(37):8062-70 – reference: 20656721 - Sex Transm Infect. 2010 Nov;86(6):415-21 – reference: 12183233 - Antimicrob Agents Chemother. 2002 Sep;46(9):2811-20 – reference: 9534233 - Microbiology. 1998 Mar;144 ( Pt 3):621-7 – reference: 21933917 - MBio. 2011;2(5). pii: e00187-11. doi: 10.1128/mBio.00187-11 – reference: 23416957 - J Antimicrob Chemother. 2013 Jun;68(6):1267-70 – reference: 10508026 - Antimicrob Agents Chemother. 1999 Oct;43(10):2468-72 – reference: 16547016 - J Bacteriol. 2006 Apr;188(7):2300-8 – reference: 22316442 - N Engl J Med. 2012 Feb 9;366(6):485-7 – reference: 24400344 - Int J STD AIDS. 2013 Feb;24(2):85-92 – reference: 18761689 - Mol Microbiol. 2008 Oct;70(2):462-78 – reference: 7608095 - J Bacteriol. 1995 Jul;177(14):4162-5 – reference: 21576437 - Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45 – reference: 23299608 - JAMA. 2013 Jan 9;309(2):163-70 – reference: 24189248 - Antimicrob Agents Chemother. 2014;58(1):624-5 – reference: 18190261 - J Infect Dis. 2007 Dec 15;196(12):1804-12 – reference: 16427026 - Biochem Pharmacol. 2006 Mar 30;71(7):910-8 – reference: 8709956 - Mol Gen Genet. 1996 Jul 19;251(5):509-17 – reference: 9465102 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1829-33 – reference: 19528266 - Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51 – reference: 19735224 - Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34 – reference: 22874837 - MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4 – reference: 18978065 - J Bacteriol. 2009 Jan;191(1):287-97 – reference: 12533487 - J Bacteriol. 2003 Feb;185(3):1101-6 – reference: 12270819 - J Bacteriol. 2002 Oct;184(20):5619-24 |
SSID | ssj0006590 |
Score | 2.4212804 |
Snippet | The contribution of drug efflux pumps in clinical isolates of
Neisseria gonorrhoeae
that express extensively drug-resistant or multidrug-resistant phenotypes... The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes... |
SourceID | swepub pubmedcentral proquest asm2 pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 3556 |
SubjectTerms | Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial diseases Bacterial diseases of the genital system Bacterial Proteins - genetics Bacterial Proteins - metabolism Biological and medical sciences Drug Resistance, Multiple, Bacterial - genetics Epidemiology. Vaccinations General aspects Genes, MDR Genes, MDR - physiology Gonorrhea Gonorrhea - microbiology Human bacterial diseases Humans Infectious diseases Mechanisms of Resistance Medical sciences Membrane Transport Proteins Membrane Transport Proteins - genetics Membrane Transport Proteins - metabolism Microbial Sensitivity Tests Mutation Neisseria gonorrhoeae Neisseria gonorrhoeae - drug effects Neisseria gonorrhoeae - genetics Pharmacology. Drug treatments |
Title | Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24733458 https://journals.asm.org/doi/10.1128/AAC.00038-14 https://www.proquest.com/docview/1534847178 https://www.proquest.com/docview/1549635133 https://pubmed.ncbi.nlm.nih.gov/PMC4068427 https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56403 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIhASQlBe4VEtCHpJHRx7_TpGBdSAgnJoUG_Wxl4nFokdJY5E-BP8Wu7M7K5fIkXQQ6zEWXttzTfrmfF8M4S8QV6AzQPbCEQ_Nti0Hxk-c2xDOIkV8NjkTPIrRl_c8wn7dOlcHhz8amQtbYtpL_qxl1dyHanCPpArsmT_Q7LVSWEHfAf5whYkDNt_kvFwKa1n1E3MZMHcwHi9nWG75MX2e3cMotqUiYyDrEiXqSy7JOvpb9BwxCPHGI5f68SMkidZncsoRxbdIdwMWqYyyCDke_yUd2d5lq_X81zwVlJRezo-k0Q6yaGbi6VmfdWJpPkCmyGqWKwivVeRnzlPFKp0ZKg76lWB4XmGETRFOfqWF3n5xySDOdTuWdaObPRZnYHVIBPgKtfIXx2ldX2q5rruugbzVSPjnlBLOVZKdR3VL7dc6x2_genmwg1ml9swAuBnsP8BYyFpYjA468mXqoZiwDawtlpKsFnMs22mp2sX9B6PzsCK8pnl3SA3LfBuZCRg-LkyIOCiFXNK31TJ17D8d82JsY61ngXsCb5ZWi3b6u6KbwAwierPss-B-jMPuFUtV1pYF_fJPe0a0YHC-QNyILIjcks1S90dkdsjnQZyRE7GquD67pRe1PzBzSk9oeO6FPvuIflZawjNE1qhmioNoVJDaJpRACRtQZbWGkJLDcFTlBpC92gILTUEB1YaQhsa8ohMPn64ODs3dAsSg4NlXhhRPwBBYQpTDEiKWYSJCKbwgyiwfM-3bS8RZsCcwI7B6PGnInGS2OFuxMwoYmAqPyaHWZ6Jp4TGHhceyND3goBxGxwDH3wfh3txP-KBZ3bIa5RhqNeXTSjdc8sPQeahlDm46R3SLSUcRrqIP_aSWVwx-m01eqWK11wx7rgFlmqwBf4Yksg65FWJnhAeP_hOkWci38JFOjZDA9f76xgGj3lsJNUhTxTi6hk0gjvEa2GxGoDl79v_ZOlclsHXSgQ3qVDbOuR9-nUQ5usZfLah4zLTfnbtGZ6TO_Xy9IIcFuuteAmuSDE9lor7GwlTOvE |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+Multidrug+Efflux+Pumps+in+the+Antimicrobial+Resistance+Property+of+Clinical+Multidrug-Resistant+Isolates+of+Neisseria+gonorrhoeae&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Golparian%2C+Daniel&rft.au=Shafer%2C+William+M.&rft.au=Ohnishi%2C+Makoto&rft.au=Unemo%2C+Magnus&rft.date=2014-06-01&rft.pub=American+Society+for+Microbiology&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=58&rft.issue=6&rft.spage=3556&rft.epage=3559&rft_id=info:doi/10.1128%2FAAC.00038-14&rft_id=info%3Apmid%2F24733458&rft.externalDocID=PMC4068427 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon |